Hyper-Accelerate Drug Development
Advance Pharmacometrics & Decision-Making with Our Secure, AI-Driven Platform
Built for Data-Driven Decisions
Our platform is designed to empower the future of drug development through a secure, cloud-native, and collaborative environment. Built for flexibility, it supports all major modeling software, allowing teams to work seamlessly without being limited by tools or formats.
With integrated data and AI capabilities, the platform enables effortless simulation and analysis, making it easy to design and run any clinical trial scenario — from the simplest to the most complex. Whether you’re optimizing dose regimens or testing adaptive trial strategies, you can set up and simulate clinical trial designs with speed and precision.
More than just a simulation tool, our platform acts as a command center, allowing you to orchestrate your entire development strategy for maximum impact. By bringing together models, data, and insights in one unified space, we help you accelerate decisions and advance drug development with confidence.
Some of Our Solutions
Ready to transform
how you design trials?
Meet IRIS
Your Expert Partner in Model-Based Decisions
A multi-agent architecture featuring MCP-based tooling to assist the user with a every increasing number of tasks, such as Q&A on internal sources, external sources, as well as analyze and run simulations automatically, for selected simulation models.
Driving Drug Development, Together
“We’re honored to have found the perfect partner in InSilicoTrials. RCPE and InSilicoTrials are combining their expertise to help engineers and researchers make data-driven decisions and deliver new levels of innovation. InSilicoTrials’ comprehensive simulation platform combined with XPS creates a single-source repository for pharmaceutical development from discovery to dosage form. This collaboration and our shared developmental efforts truly set the gold standard for modeling and simulation in life sciences.”
“We are very delighted to initiate this collaboration with InSilicoTrials and have the opportunity to optimize and accelerate our next clinical steps. Integrating their industry-leading AI and computational modeling solutions in the development plan of our promising disease-modifying drug will allow us to address the pressing challenges faced by individuals suffering from neurological disorders.”
“Since the birth of our company we have dreamed of carrying out a preclinical development of a vaccine or a monoclonal antibody while minimizing waste, which is why the LAB 4.0 project was born. We are now excited to partner with InSilicoTrials to take this concept further and extend it to the point where we can simulate the entire biopharmaceutical development chain from lab, to animal testing, to clinic, while dramatically reducing related risks.”
“We’re honored to have found the perfect partner in InSilicoTrials. RCPE and InSilicoTrials are combining their expertise to help engineers and researchers make data-driven decisions and deliver new levels of innovation. InSilicoTrials’ comprehensive simulation platform combined with XPS creates a single-source repository for pharmaceutical development from discovery to dosage form. This collaboration and our shared developmental efforts truly set the gold standard for modeling and simulation in life sciences.”
“We are very delighted to initiate this collaboration with InSilicoTrials and have the opportunity to optimize and accelerate our next clinical steps. Integrating their industry-leading AI and computational modeling solutions in the development plan of our promising disease-modifying drug will allow us to address the pressing challenges faced by individuals suffering from neurological disorders.”
Previous
Next
Let’s Talk About Your Next Project!
Get in touch with our team and explore how we can support your drug development journey.